Europe Blood Irradiation Market Forecast to 2028 - COVID-19 Impact and Regional Analysis

List of Tables

The blood irradiation market in Europe is expected to grow from US$ 26.90 million in 2022 to US$ 40.24 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2022 to 2028.

Rise in Healthcare Expenditure and Government Initiatives Bolsters Europe Blood Irradiation Market

The therapeutic landscape of communicable and noncommunicable diseases is evolving with time and technology, increasing healthcare expenditure, and surging awareness in a large population. X-ray and gamma irradiators are widely used for blood irradiation to ensure patient safety and prevent further complications. Blood irradiation helps manage hematological malignancies and prevents transfusion-associated graft-versus-host (TGVH) disease. The FDA has approved the use of blood irradiators, along with implementing tighter security measures to reduce the risk of unauthorized use of radioactive materials. The Serious Hazards of Blood Transfusion (SHOT) scheme of the UK government supports patient safety by analyzing anonymized information gathered on adverse events and reactions reported by from healthcare organizations involved in the blood and blood components transfusion after the transfusion procedures. Moreover, European Blood Alliance (EBA), Voluntary Blood Donation in Rhodope, and various other government and nongovernment organizations/projects from European countries are creating awareness among people regarding blood donation to fulfill the increasing demand for blood. Thus, such government and nongovernment initiatives for encouraging blood donation are driving the growth of the blood irradiation market.

Market Overview

Europe is the second-largest market for blood irradiation, and the market growth in this region is attributed to factors such as the rising prevalence of cancer, cardiac stroke, diabetes, and various other noncommunicable chronic diseases. In addition, growing funding for research & development activities is likely to provide opportunities for the market players in the coming years. Moreover, the pharmaceutical industry in Germany holds the fourth largest position with small and mid-sized companies. The country is likely to remain one of the most attractive destinations for the Europe healthcare industry over the coming years in terms of treatment. The industry's growth is driven by various factors such as increasing investment for research and development, and advanced healthcare facilities like hospitals, blood banks, and clinics. The blood irradiation market in Germany is primarily driven by countries aging population, socio-political environment and high per capita healthcare expenditure.

Europe Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)

Europe Blood Irradiation Market Segmentation

The Europe blood irradiation market is segmented into type , indication, end user, and country.

Based on type ,the market is segmented into intravenous laser blood irradiation, transcutaneous laser blood irradiation, and extracorporeal blood irradiation. The intravenous laser blood irradiation segment registered the largest market share in 2022.

Based on indication , the market is segmented into acute leukemia, lymphoma, solid tumors, pelvic tumors and others. The acute leukemia segment held the largest market share in 2022.

Based on end user, the market is segmented into hospitals, blood banks, diagnostics clinics, and research institutes. The hospital segment held the largest market share in 2022.

Based on country, the market is segmented into U.K., Germany, France, Italy, Spain and Rest of Europe. Germany dominated the market share in 2022.

Hitachi, Ltd.; Best Theratronics Ltd.; Gilardoni S.p.A.; Gamma-Service Medical GmbH; Typenex Medical; and Actemium are the leading companies operating in the blood irradiation market in the region.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Blood Irradiation Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe Blood Irradiation Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: BMIRE00027192

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Blood Irradiation Market - By Type
- 1.3.2 Europe Blood Irradiation Market - By Indication
- 1.3.3 Europe Blood Irradiation Market - By End User
- 1.3.4 Europe Blood Irradiation Market - By Country

2. Europe Blood Irradiation Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Blood Irradiation Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Europe PEST Analysis
4.3 Experts Opinion

5. Europe Blood Irradiation Market- Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increase in Communicable and Noncommunicable Diseases
- 5.1.2 Rise in Healthcare Expenditure and Government Initiatives
5.2 Market Restraints
- 5.2.1 Stringent Regulatory Policies, High Cost, and Challenges with Blood Component Irradiation
5.3 Market Opportunities
- 5.3.1 Increasing Immunocompromised Population and Rising Incidences of Leukemia and Lymphoma
5.4 Future Trends
- 5.4.1 Technological Advancements and Product Launches
5.5 Impact Analysis

6. Blood Irradiation Market- Europe Analysis

6.1 Europe Blood Irradiation Market Revenue Forecasts and Analysis
- 6.1.1 Overview
- 6.1.2 Europe Blood Irradiation Market, and Forecast to 2028 (Units)

7. Europe Blood Irradiation Market Analysis - By Type

7.1 Overview
7.2 Europe Blood Irradiation Market Revenue Share, by Type (2021 and 2028)
- 7.2.1 Europe: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
7.3 Intravenous Laser Blood Radiation
- 7.3.1 Overview
- 7.3.2 Europe Intravenous Laser Blood Radiation: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Transcutaneous Laser Blood Radiation
- 7.4.1 Overview
- 7.4.2 Europe Transcutaneous Laser Blood Radiation: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Extracorporeal Blood Radiation
- 7.5.1 Overview
- 7.5.2 Europe Extracorporeal Blood Radiation: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Blood Irradiation Market -By End User

8.1 Overview
8.2 Europe Blood Irradiation Market, by End User, 2021 and 2028 (%)
- 8.2.1 Europe: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Europe Hospitals: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Blood Banks
- 8.4.1 Overview
- 8.4.2 Europe Blood Banks: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Diagnostic Centers
- 8.5.1 Overview
- 8.5.2 Europe Diagnostic Centers: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Research Institutes
- 8.6.1 Overview
- 8.6.2 Europe Research Institutes: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)

9. Europe Blood Irradiation Market -By Indication

9.1 Overview
9.2 Europe Blood Irradiation Market, by Indication, 2021 and 2028 (%)
- 9.2.1 Europe: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
9.3 Acute Leukemia
- 9.3.1 Overview
- 9.3.2 Europe Acute Leukemia: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Solid Tumors
- 9.4.1 Overview
- 9.4.2 Europe Solid Tumors: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Pelvic Tumors
- 9.5.1 Overview
- 9.5.2 Europe Pelvic Tumors: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Lymphoma
- 9.6.1 Overview
- 9.6.2 Europe Lymphoma: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Others
- 9.7.1 Overview
- 9.7.2 Europe Others: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)

10. Europe Blood Irradiation Market - Country Analysis

10.1 Europe: Blood Irradiation Market
- 10.1.1 Overview
- 10.1.2 Europe: Blood Irradiation Market, by Country, 2021 & 2028 (%)
  - 10.1.2.1 Germany: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 Germany: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.3 Germany: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.1.4 Germany: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
    - 10.1.2.1.5 Germany: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
  - 10.1.2.2 UK: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 UK: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.3 UK: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.2.4 UK: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
    - 10.1.2.2.5 UK: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
  - 10.1.2.3 France: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 France: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.3 France: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.3.4 France: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
    - 10.1.2.3.5 France: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
  - 10.1.2.4 Italy: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.4.1 Overview
    - 10.1.2.4.2 Italy: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.4.3 Italy: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.4.4 Italy: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
    - 10.1.2.4.5 Italy: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
  - 10.1.2.5 Spain: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.5.1 Overview
    - 10.1.2.5.2 Spain: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.5.3 Spain: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.5.4 Spain: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
    - 10.1.2.5.5 Spain: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)
  - 10.1.2.6 Rest of Europe: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.6.1 Overview
    - 10.1.2.6.2 Rest of Europe: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.6.3 Rest of Europe: Blood Irradiation Market, by Type, 2019-2028 (US$ Million)
    - 10.1.2.6.4 Rest of Europe: Blood Irradiation Market, by End-Users, 2019-2028 (US$ Million)
    - 10.1.2.6.5 Rest of Europe: Blood Irradiation Market, by Indication, 2019-2028 (US$ Million)

11. Europe Blood Irradiation Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Europe Blood Irradiation Market, 2021-2028
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Hitachi, Ltd.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Best Theratronics Ltd.,
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Gilardoni S.p.A.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Gamma-Service Medical GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Typenex Medical
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Actemium
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms